Author: Kenneth Mack | MedLuna.com

1.

Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society

Oskoui M, Pringsheim T, Holler-Managan Y, Potrebic S, Billinghurst L, Gloss D, et al.

Headache . 2019 Sep; 59(8):1158-1173. PMID: 31529481

Objective: To provide evidence-based recommendations for the acute symptomatic treatment of children and adolescents with migraine. Methods: We performed a systematic review of the literature and rated risk of bias...

2.

New Guidelines: Interpretation, Application and the Future

Hershey A, Oskoui M, Pringsheim T, Holler-Managan Y, Potrebic S, Billinghurst L, et al.

Headache . 2019 Sep; 59(8):1133-1143. PMID: 31529478

No abstract available.

3.

Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society

Oskoui M, Pringsheim T, Billinghurst L, Potrebic S, Gersz E, Gloss D, et al.

Headache . 2019 Sep; 59(8):1144-1157. PMID: 31529477

Objective: To provide updated evidence-based recommendations for migraine prevention using pharmacologic treatment with or without cognitive behavioral therapy in the pediatric population. Methods: The authors systematically reviewed literature from January...

4.

Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society

Oskoui M, Pringsheim T, Holler-Managan Y, Potrebic S, Billinghurst L, Gloss D, et al.

Neurology . 2019 Aug; 93(11):487-499. PMID: 31413171

Objective: To provide evidence-based recommendations for the acute symptomatic treatment of children and adolescents with migraine. Methods: We performed a systematic review of the literature and rated risk of bias...

5.

Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society

Oskoui M, Pringsheim T, Billinghurst L, Potrebic S, Gersz E, Gloss D, et al.

Neurology . 2019 Aug; 93(11):500-509. PMID: 31413170

Objective: To provide updated evidence-based recommendations for migraine prevention using pharmacologic treatment with or without cognitive behavioral therapy in the pediatric population. Methods: The authors systematically reviewed literature from January...

6.

Fragile X-associated Tremor/Ataxia Syndrome in an Adolescent Female

Mittal S, Mack K, Bower J

Mov Disord Clin Pract . 2019 Mar; 4(5):778-780. PMID: 30838288

No abstract available.

7.

In memoriam: Donald W. Lewis, MD (1951-2012)

Hershey A, Winner P, Linder S, Gladstein J, Yonker M, Mack K, et al.

Headache . 2012 May; 52(5):720-1. PMID: 22563994

No abstract available.

8.

Ischemic stroke as the presenting symptom of primary hyperparathyroidism due to multiple endocrine neoplasia type 1

Mitre N, Mack K, Babovic-Vuksanovic D, Thompson G, Kumar S

J Pediatr . 2008 Oct; 153(4):582-5. PMID: 18847624

We report a 14-year-old boy whose initial presentation of primary hyperparathyroidism was ischemic stroke in the absence of hypertension. We propose measurement of serum calcium and parathyroid hormone in all...

9.

Regarding "antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders"

Budman C, Coffey B, Dure L, Gilbert D, Juncos J, Kaplan E, et al.

Biol Psychiatry . 2005 Oct; 58(11):917. PMID: 16242121

No abstract available.